Open original FDA record ↗Recall record
- FDA identifier
- Z-1265-2020
- Company in FDA record
- Abbott Point Of Care Inc.
- FDA classification date
- Feb 18, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Marketed without a 510(k). Abbott Point of Care has determined that it does not have sufficient clinical evidence to fully characterize the performance of the blue i-STAT G3+ cartridges and therefore will no longer distribute the i-STAT G3+ (blue) cartridge in the United States as of May 1, 2020.
Source facts
- Action
- On January 15, 2020, the recalling firm notified customers via letters, emails, follow-up phone calls/visits by sales representatives, and a website posting at www.pointofcare.abbott. Customers were instructed to take the following actions: " During the transition, clinicians and laboratory staff should be informed that the performance of the i-STAT G3+ (BLUE) cartridge has not been fully characterized by Abbott. " Clinicians should be advised to consider a patients signs, symptoms, history, and results of other diagnostic tests when interpreting results from these cartridges. If the results do not match the patients clinical presentation, the patient sample should be retested using an alternate test method or a reference laboratory. " Report any questions or concerns you have regarding the i-STAT G3+ cartridge performance to Abbott Point of Care Technical Support at 1-800-366-8020 option 1, or via email at techsvc@apoc.abbott.com. If you have forwarded any i-STAT G3+ (BLUE), 6+ (WHITE), E3+ (WHITE), and EC4+ (WHITE) cartridges to another facility, we request that you please provide a copy of this letter to them. ***Updated 4/7/2020*** On April 2, 2020, Abbott Point of Care sent an additional letter communicating the following: In response to the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) are allowing the use of the i-STAT CG4+(blue) and i-STAT G3+ (blue) blood gas cartridges in laboratories and facilities that hold a Certificate of Compliance or Accreditation to run tests of moderate complexity. Specifically, during the COVID-19 pandemic Abbott Point of Care may continue to distribute the i-STAT CG4+ (blue) and i-STAT G3+ (blue) cartridges, and facilities that possess a non-waived CLIA certificate (i.e., facilities that hold a Certificate of Compliance or Accreditation) may use them with venous and arterial whole blood samples as tests of moderate comp
- Initiated
- 2020-01-14
- Root cause
- No Marketing Application
- Terminated
- 2021-04-12
- Distribution
- US Nationwide distribution.
- Recall number
- Z-1265-2020
- Recall status
- Terminated
- CDRH record ID
- 179124
- FDA classified
- 2020-02-18
- Recall event number
- 84730